Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (678) Hemodialysis
...CenterWatch: Clinical Trials in Category (678) Hemodialysis Hemodialysis State • New York New York Great Neck : Biomedical Research Alliance of New York End-stage ...
View Page

2.  CenterWatch: Clinical Trials in Category (373) Anemia
...X]   Uruguay • [X]   Venezuela Alabama Birmingham : Research Site: A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia Birmingham : Research Site: A Study of Intravenous Mircera for the ...
...Patients With Renal Anemia. Los Angeles : Research Site: A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia Los Angeles : Research Site: A Study of Intravenous Mircera for ...
View Page

3.  Study Posting (77) Trial #134393, Hemodialysis, Great Neck, NY
...Study Posting (77) Trial #134393, Hemodialysis, Great Neck, NY Trial Information End-stage Renal Disease Hemodialysis The purpose of this study is to test a new liquid drug (during the dialysis ...
View Page

4.  Study Posting (2348) Trial #75764, Hemodialysis, New York, NY
...Study Posting (2348) Trial #75764, Hemodialysis, New York, NY Trial Information Linezolid Vs Vancomycin/Cefazolin in the Treatment of Hemodialysis Patients with Catheter-Related Gram-Positive Bloodstream Infections [A5951105] The purpose of this research study ...
View Page

5.  Study Posting (77) Trial #157840, Hemodialysis, New York, NY
...Study Posting (77) Trial #157840, Hemodialysis, New York, NY Trial Information Clinical trial to test a study device for Vascular Access Grafts in Hemodialysis Patients with End Stage Renal Disease The purpose of the study is to find out ...
View Page

6.  Study Posting (4519) Trial #112662, Anemia, Västervik, Sweden
...Sweden Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

7.  Study Posting (4519) Trial #112664, Anemia, Värnamo, Sweden
...Sweden Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

8.  Study Posting (4519) Trial #105317, Anemia, Evora, Portugal
...Portugal Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

9.  Study Posting (4519) Trial #105369, Anemia, Aveiro, Portugal
...Portugal Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

10.  Study Posting (4519) Trial #99872, Anemia, Rimini, Italy
...Italy Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

11.  Study Posting (4519) Trial #99818, Anemia, Pavia, Italy
...Italy Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

12.  Study Posting (4519) Trial #102208, Anemia, Palermo, Italy
...Italy Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

13.  Study Posting (4519) Trial #126718, Anemia, Arenzano, Italy
...Italy Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

14.  Study Posting (4519) Trial #105137, Anemia, Veria, Greece
...Greece Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

15.  Study Posting (4519) Trial #105168, Anemia, Thessaloniki, Greece
...Greece Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

16.  Study Posting (4519) Trial #105131, Anemia, Piraeus, Greece
...Greece Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

17.  Study Posting (4519) Trial #105187, Anemia, Athens, Greece
...Greece Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

18.  Study Posting (4519) Trial #102717, Anemia, Weinheim, Germany
...Germany Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

19.  Study Posting (4519) Trial #102716, Anemia, Weiden, Germany
...Germany Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page

20.  Study Posting (4519) Trial #148132, Anemia, Völklingen, Germany
...Germany Trial Information A Study of NeoRecormon (Epoetin Beta) in the Treatment of Patients on Hemodialysis Status: Completed Protocol Number: MA17502 Sponsor: F Hoffman-La Roche Ltd Company Division: Pharmaceutical Official ...
...A randomized, open-label study of the effect of NeoRecormon on haemoglobin level/correction in hemodialysis patients. Brief Summary: This study will assess the efficacy of subcutaneous injections of NeoRecormon in ...
View Page